Waldenström's macroglobulinemia surgery: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Waldenström's macroglobulinemia}} {{CMG}} ==Overview== == Surgery == Recently, autologous bone marrow transplantation has been added to the available treatmen...")
 
 
(19 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Waldenström's macroglobulinemia}}
{{Waldenström's macroglobulinemia}}
{{CMG}}
{{CMG}}; {{AE}} {{S.M.}}, {{MGS}}; {{GRR}} {{Nat}}
 
==Overview==
==Overview==
== Surgery ==
[[Surgery]] is not the [[first-line treatment]] option for [[patients]] with [[Waldenström's macroglobulinemia|Waldenstrom's macroglobulinemia]]. [[Stem cell transplant]] is usually reserved for [[patients]] with either [[relapse]]<nowiki/>or [[refractory]] [[Waldenström's macroglobulinemia|Waldenstrom's macroglobulinemia]]. In very [[rare]] [[Case-based reasoning|cases]], laporotomy or laproscopy might be required.
Recently, [[autologous bone marrow transplantation]] has been added to the available treatment options.<ref name="Yang">{{cite journal | author=Yang L, Wen B, Li H, Yang M, Jin Y, Yang S, Tao J | title=Autologous peripheral blood stem cell transplantation for Waldenstrom's macroglobulinemia | journal=Bone Marrow Transplant | year=1999 | pages=929-30 | volume=24 | issue=8  | id=PMID 10516708}}</ref><ref name="Martino">{{cite journal | author=Martino R, Shah A, Romero P, Brunet S, Sierra J, Domingo-Albos A, Fruchtman S, Isola L | title=Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia | journal=Bone Marrow Transplant | year=1999 | pages=747-9 | volume=23 | issue=7  | id=PMID 10218857}}</ref><ref name="Anagnostopoulos">{{cite journal | author=Anagnostopoulos A, Dimopoulos MA, Aleman A, Weber D, Alexanian R, Champlin R, Giralt S | title=High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia | journal=Bone Marrow Transplant | year=2001 | pages=1027-9 | volume=27 | issue=10  | id=PMID 11438816}}</ref><ref name="Tournilhac">{{cite journal | author=Tournilhac O, Leblond V, Tabrizi R, Gressin R, Senecal D, Milpied N, Cazin B, Divine M, Dreyfus B, Cahn JY, Pignon B, Desablens B, Perrier JF, Bay JO, Travade P | title=Transplantation in Waldenstrom's macroglobulinemia--the French experience | journal=Semin Oncol | year=2003 | pages=291-6 | volume=30 | issue=2  | id=PMID 12720155}}</ref>
 
==Surgery==
*[[Stem cell transplant]] is usually reserved for [[patients]] when either [[lymphoma]] comes [[back]] ([[Recurrence plot|recurs]]/[[Relapse|relapses]]) after [[Treatments|treatment]] or doesn’t [[Response element|respond]] to other [[treatments]] (called [[refractory]] [[disease]]).<ref name="sure">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref>
*Many [[People's Solidarity|people]] with [[Waldenström's macroglobulinemia|Waldenstrom's macroglobulinemia]] are [[Old age|older]] or may not be in good [[health]], so a [[stem cell transplant]] may not be a good [[Treatments|treatment]] option for them.
*In very [[rare]] [[Case-based reasoning|cases]], laporotomy or laproscopy might be required.
 
==References==
==References==
{{reflist|2}}
{{Reflist|2}}
 
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Blood]]
[[Category:Blood]]
[[Category:Oncology]]
[[Category:Hematology]]
[[Category:Hematology]]

Latest revision as of 19:01, 15 August 2019

Waldenström's macroglobulinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Waldenström's macroglobulinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Bone Marrow Aspiration and Biopsy

Electrophoresis and Immunofixation

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Waldenström's macroglobulinemia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Waldenström's macroglobulinemia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Waldenström's macroglobulinemia surgery

CDC on Waldenström's macroglobulinemia surgery

Waldenström's macroglobulinemia surgery in the news

Blogs on Waldenström's macroglobulinemia surgery

Directions to Hospitals Treating Waldenström's macroglobulinemia

Risk calculators and risk factors for Waldenström's macroglobulinemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2], Mirdula Sharma, MBBS [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Overview

Surgery is not the first-line treatment option for patients with Waldenstrom's macroglobulinemia. Stem cell transplant is usually reserved for patients with either relapseor refractory Waldenstrom's macroglobulinemia. In very rare cases, laporotomy or laproscopy might be required.

Surgery

References

  1. Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015

Template:WH Template:WS